Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The "Label-free Array System Market Size, Share & Trends Analysis Report By Type (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global label-free array system market is projected to reach an impressive USD 799.59 million by 2030, displaying a steady Compound Annual Growth Rate (CAGR) of 7.42% from 2023 to 2030. This significant growth is driven by several key factors.
Biotech Startups Fuel Growth
The label-free array system market is experiencing substantial growth, thanks in part to increased fundraising by biotech startups dedicated to pioneering innovative products. These startups are driving research and development in the field, propelling the demand for label-free array systems.
Emerging Markets Embrace Personalized Medicine
Emerging markets are witnessing a surge in awareness regarding personalized diagnostic and therapeutic treatments. This heightened awareness is contributing significantly to the label-free array system market's expansion. These systems are essential for the development and delivery of personalized healthcare solutions.
Innovative Technology: Surface Plasmon Resonance (SPR)
Label-free array systems leverage Surface Plasmon Resonance (SPR) technology, allowing the detection and quantification of biomolecules in complex samples without the need for fluorescent or radioactive labels. This technology offers several advantages, including enhanced safety and cost-effectiveness compared to traditional labeling methods. Moreover, label-free array systems provide real-time insights into biomolecule interactions, offering dynamic and quantitative information on binding kinetics and affinity.
Diverse Applications Drive Demand
Companies are continually expanding the application scope for label-free array systems, making them indispensable across various sectors. These systems find application in Biologics & Small Molecules Research, bioprocessing, COVID-19 research, GxP applications, lead optimization and selection, titer and impurity testing, and target ID and validation, according to Sartorius.
Technological Advancements and Growth
Advancements in material science, computational design, and nanofabrication have led to the development of label-free protein microarray approaches. These approaches have demonstrated significant results in protein profiling, drug discovery, biomarker screening, and drug target identification. This continuous technological progress is expected to further enhance the growth of label-free array systems in the market.
North America Leads the Way
North America has secured the lion's share of the market, holding 47.20% of the overall market share. The region's well-established healthcare facilities, substantial investment in R&D, and growing awareness among healthcare professionals and patients regarding early disease detection and treatment are driving product adoption and market growth.
Market Segment Highlights
- Surface Plasmon Resonance Dominates: Surface plasmon resonance is expected to capture the majority of the label-free array system market share in 2022 due to increasing R&D investment in biomedical research.
- Key Application: Drug Discovery: Drug discovery remains the dominant application, driven by the increasing use of personalized medicines in developing countries.
- Academic and Research Institutions Thrive: The academic and research institutions segment is poised for significant growth, thanks to increasing grants and financial assistance from government and corporate sources.
Key Players in the Market
Leading players in the label-free array system market include Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, F. Hoffmann-La Roche AG, and Bio-Rad Laboratories, Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $455.91 Million |
| Forecasted Market Value (USD) by 2030 | $799.59 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Type Business Analysis
4.1. Label-free Array Systems Market: Type Movement Analysis
4.2. Surface Plasmon Resonance
4.2.1. Surface Plasmon Resonance Market, 2018 - 2030 (USD Million)
4.3. Bio-layer Interferometry
4.3.1. Bio-layer Interferometry Market, 2018 - 2030 (USD Million)
4.4. Cellular Dielectric Spectroscopy
4.4.1. Cellular Dielectric Spectroscopy Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Label-free Array Systems Market: Application Movement Analysis
5.2. Drug Discovery
5.2.1. Drug Discovery Market, 2018 - 2030 (USD Million)
5.3. Protein Interface Analysis
5.3.1. Protein Interface Analysis Market, 2018 - 2030 (USD Million)
5.4. Antibody Characterization
5.4.1. Antibody Characterization Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-user Business Analysis
6.1. Label-free Array Systems Market: End-user Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
6.4. CRO
6.4.1. CRO Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
Chapter 8. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/nhzexp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
